268 related articles for article (PubMed ID: 20525350)
1. Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates.
Estrela-Lima A; Araújo MS; Costa-Neto JM; Teixeira-Carvalho A; Barrouin-Melo SM; Cardoso SV; Martins-Filho OA; Serakides R; Cassali GD
BMC Cancer; 2010 Jun; 10():256. PubMed ID: 20525350
[TBL] [Abstract][Full Text] [Related]
2. Understanding of the immunological heterogeneity of canine mammary carcinomas to provide immunophenotypic features of circulating leukocytes as clinically relevant prognostic biomarkers.
Estrela-Lima A; Araújo MS; da Costa-Neto JM; Ribeiro LG; Damasceno KA; D'Assis MJ; Martins-Filho OA; Teixeira-Carvalho A; Serakides R; Cassali GD
Breast Cancer Res Treat; 2012 Feb; 131(3):751-63. PubMed ID: 21448671
[TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating CD4
Franzoni MS; Brandi A; de Oliveira Matos Prado JK; Elias F; Dalmolin F; de Faria Lainetti P; Prado MCM; Leis-Filho AF; Fonseca-Alves CE
Res Vet Sci; 2019 Oct; 126():29-36. PubMed ID: 31425936
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of blood T-lymphocyte subpopulations involved in host cellular immunity in dogs with mammary cancer.
Karayannopoulou M; Anagnostou T; Margariti A; Kostakis C; Kritsepi-Konstantinou M; Psalla D; Savvas I
Vet Immunol Immunopathol; 2017 Apr; 186():45-50. PubMed ID: 28413049
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
[TBL] [Abstract][Full Text] [Related]
6. Significance of tumor-infiltrating immune cells in spontaneous canine mammary gland tumor: 140 cases.
Saeki K; Endo Y; Uchida K; Nishimura R; Sasaki N; Nakagawa T
J Vet Med Sci; 2012 Feb; 74(2):227-30. PubMed ID: 21937855
[TBL] [Abstract][Full Text] [Related]
7. Plasma biomarkers profile of female dogs with mammary carcinoma and its association with clinical and pathological features.
Estrela-Lima A; Araújo MS; Soares RP; Ribeiro LG; Damasceno KA; Costa AT; Teixeira-Carvalho A; Martins-Filho OA; Cassali GD
Vet Comp Oncol; 2016 Mar; 14(1):88-100. PubMed ID: 24571435
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
9. The effect of naltrexone as a carboplatin chemotherapy-associated drug on the immune response, quality of life and survival of dogs with mammary carcinoma.
Machado MC; da Costa-Neto JM; Portela RD; D'Assis MJMH; Martins-Filho OA; Barrouin-Melo SM; Borges NF; Silva FL; Estrela-Lima A
PLoS One; 2018; 13(10):e0204830. PubMed ID: 30286124
[TBL] [Abstract][Full Text] [Related]
10. A role for T-lymphocytes in human breast cancer and in canine mammary tumors.
Carvalho MI; Pires I; Prada J; Queiroga FL
Biomed Res Int; 2014; 2014():130894. PubMed ID: 24672781
[TBL] [Abstract][Full Text] [Related]
11. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
Wang K; Shen T; Siegal GP; Wei S
Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
[TBL] [Abstract][Full Text] [Related]
12. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
Hudnall SD; Betancourt E; Barnhart E; Patel J
Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
[TBL] [Abstract][Full Text] [Related]
13. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.
Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC
Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotyping of skin-infiltrating T-cell subsets in dogs with atopic dermatitis.
Sinke JD; Thepen T; Bihari IC; Rutten VP; Willemse T
Vet Immunol Immunopathol; 1997 Jun; 57(1-2):13-23. PubMed ID: 9239834
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating CD4+ T lymphocytes in early breast cancer reflect lymph node involvement.
Macchetti AH; Marana HR; Silva JS; de Andrade JM; Ribeiro-Silva A; Bighetti S
Clinics (Sao Paulo); 2006 Jun; 61(3):203-8. PubMed ID: 16832552
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Relevance of the Relative Presence of CD4, CD8 and CD20 Expressing Tumor Infiltrating Lymphocytes in Operable Non-small Cell Lung Cancer Patients.
Giatromanolaki A; Anestopoulos I; Panayiotidis MI; Mitrakas A; Pappa A; Koukourakis MI
Anticancer Res; 2021 Aug; 41(8):3989-3995. PubMed ID: 34281863
[TBL] [Abstract][Full Text] [Related]
17. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
18. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
19. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
Alonso-Álvarez S; Vidriales MB; Caballero MD; Blanco O; Puig N; Martin A; Peñarrubia MJ; Zato E; Galende J; Bárez A; Alcoceba M; Orfão A; González M; García-Sanz R
Leuk Lymphoma; 2017 May; 58(5):1144-1152. PubMed ID: 27733075
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
[Next] [New Search]